{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:19:58Z","timestamp":1793089198156,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005128.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000}}],"reference-count":113,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005128.pub4","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T05:33:01Z","timestamp":1677735181000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Interventions for preventing and treating kidney disease in IgA vasculitis"],"prefix":"10.1002","volume":"2023","author":[{"given":"Deirdre","family":"Hahn","sequence":"additional","affiliation":[{"name":"Department of Nephrology; The Children's Hospital at Westmead; Westmead Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth M","family":"Hodson","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health; The University of Sydney; Sydney Australia"},{"name":"Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Craig","sequence":"additional","affiliation":[{"name":"Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia"},{"name":"College of Medicine and Public Health; Flinders University; Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD005128.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ki.2010.150","article-title":"Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schonlein Purpura","volume":"78","author":"Pillebout","year":"2010","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0002|cit2","unstructured":"Pillebout E Alberti C Guillevin L Thervet E CESAR Study Group Prospective randomized study of cyclophosphamide and steroid versus steroid alone therapy in adult patients with severe Henoch Schonlein Purpura (HSP) [abstract no: SA275] World Congress of Nephrology; 2009 May 22-26; Milan, Italy 2009"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD005128.pub4-BIB0003|cit3","first-page":"150A","article-title":"Prospective randomized study of cyclophosphamide and steroid versus steroid alone therapy in adults patients with severe Henoch Schonlein Purpura (HSP)-CESAR study group [abstract no: TH-PO175]","volume":"20","author":"Pillebout","year":"2009","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD005128.pub4-BIB0004|cit4","first-page":"1817","article-title":"Comparison of Leflunomide and Mycophenolate mofetil in children with Henoch-Schonlein nephritis [abstract no: PO-163]","volume":"31","author":"Du","year":"2016","journal-title":"Pediatric Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD005128.pub4-BIB0005|cit5","first-page":"1457","article-title":"Randomised placebo controlled trial to assess the role of early prednisolone on the development and progression of Henoch-Schonlein Purpura Nephritis [abstract no: 270 (FC)]","volume":"22","author":"Dudley","year":"2007","journal-title":"Pediatric Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD005128.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/archdischild-2013-303642","article-title":"Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein Purpura (HSP)","volume":"98","author":"Dudley","year":"2013","journal-title":"Archives of Disease in Childhood"},{"issue":"Abstracts","key":"10.1002\/14651858.CD005128.pub4-BIB0007|cit7","first-page":"47A","article-title":"Randomised placebo controlled trial to assess the role of early prednisolone on the development and progression of Henoch-Schonlein Purpura nephritis [abstract no: SA-FC056]","volume":"18","author":"Dudley","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD005128.pub4-BIB0008|cit8","first-page":"1753","article-title":"Efficacy of mycophenolate mofetil and prednisone compared to azathioprine and prednisone treatment in children with Henoch-Shonlein purpura nephritis [abstract no: FP-S26-1]","volume":"31","author":"Endo","year":"2016","journal-title":"Pediatric Nephrology"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD005128.pub4-BIB0009|cit9","first-page":"558A","article-title":"Henoch-Schonlein Purpura nephritis: comparison of two therapies (azathioprine vs mycophenolate) and it's effect on the urinary excretion of MCP-1 [abstract no: FR-PO1921]","volume":"22","author":"Fuentes","year":"2011","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD005128.pub4-BIB0010|cit10","first-page":"1802","article-title":"Comparison of azathioprine vs mofetil mycophenolate for Henoch-Schonlein nephritis treatment [abstract no: 39]","volume":"25","author":"Fuentes","year":"2010","journal-title":"Pediatric Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD005128.pub4-BIB0011|cit11","first-page":"338","article-title":"Efficacy and safety of mycophenolate mofetil versus cyclophosphamide in the treatment of Henoch-Schonlein purpura nephritis with nephrotic-range proteinuria in children: a prospective randomized controlled trial","volume":"23","author":"Geng","year":"2021","journal-title":"Zhongguo Dangdai Erke Zazhi"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0012|cit12","unstructured":"He YY Hongmei S Lihua S Min W Preventive value of heparin on the occurrence of nephropathy in Henoch-Schoenlein Purpura: a randomized controlled clinical trial [abstract no: 0364] 23rd International Congress of Pediatrics; 2001 Sep 9-14; Beijing, China 2001"},{"issue":"2","key":"10.1002\/14651858.CD005128.pub4-BIB0013|cit13","first-page":"99","article-title":"Preventive effect of heparin on the development of nephropathy in Henoch-Schoenlein purpura-a randomized controlled clinical trial","volume":"40","author":"He","year":"2002","journal-title":"Chinese Journal of Pediatrics"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1741-7015-2-7","article-title":"A randomized, placebo-controlled trial of prednisone in early Henoch Schonlein purpura [ISRCTN85109383]","volume":"2","author":"Huber","year":"2004","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0015|cit15","unstructured":"Islek I Sezer T Totan M Cakir M Kucukoduk S The effect of profilactic prednisolon therapy on renal involvement in Henoch Schonlein vasculitis [abstract] XXXVI Congress of the European Renal Association European Dialysis & Transplant Association; 1999 Sep 5-8; Madrid, Spain 1999 103"},{"issue":"9","key":"10.1002\/14651858.CD005128.pub4-BIB0016|cit16","first-page":"1584","article-title":"Cyclosporine A (CyA) versus MP pulses (MP) in severe Henoch-Schoenlein nephritis (HSN): outcome after 2 year follow-up [abstract no: O05]","volume":"23","author":"Jauhola","year":"2008","journal-title":"Pediatric Nephrology"},{"issue":"12","key":"10.1002\/14651858.CD005128.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00467-011-1919-5","article-title":"Cyclosporine A vs. methylprednisolone for Henoch-Schonlein nephritis: a randomized trial [Erratum in: Pediatr Nephrol. 2011 Dec;26(12):2263-4]","volume":"26","author":"Jauhola","year":"2011","journal-title":"Pediatric Nephrology"},{"issue":"11","key":"10.1002\/14651858.CD005128.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/adc.2009.167874","article-title":"Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study","volume":"95","author":"Jauhola","year":"2010","journal-title":"Archives of Disease in Childhood"},{"issue":"11","key":"10.1002\/14651858.CD005128.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/adc.2009.182394","article-title":"Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children","volume":"95","author":"Jauhola","year":"2010","journal-title":"Archives of Disease in Childhood"},{"issue":"10","key":"10.1002\/14651858.CD005128.pub4-BIB0020|cit20","first-page":"1531","article-title":"Cyclosporine A (CyA) versus MP pulses (MP) in the treatment of severe Henoch-Schonlein Nephritis (HSN) [abstract no: COD. PP38]","volume":"21","author":"Ronkainen","year":"2006","journal-title":"Pediatric Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD005128.pub4-BIB0021|cit21","first-page":"955","article-title":"Clinical effect of double filtration plasmapheresis combined with glucocorticoid and immunosuppressant in treatment of children with severe Henoch-Schonlein purpura nephritis","volume":"21","author":"Liu","year":"2019","journal-title":"Zhongguo Dangdai Erke Zazhi"},{"issue":"2","key":"10.1002\/14651858.CD005128.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/BF01958961","article-title":"Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura","volume":"151","author":"Mollica","year":"1992","journal-title":"European Journal of Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD005128.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1651-2227.1990.tb11365.x","article-title":"Prophylaxis and therapy of glomerulonephritis in the course of anaphylactoid purpura. The results of a polycentric clinical trial","volume":"79","author":"Peratoner","year":"1990","journal-title":"Acta Paediatrica Scandinavica"},{"issue":"11","key":"10.1002\/14651858.CD005128.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/adc.2009.167874","article-title":"Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study","volume":"95","author":"Jauhola","year":"2010","journal-title":"Archives of Disease in Childhood"},{"issue":"9","key":"10.1002\/14651858.CD005128.pub4-BIB0025|cit25","first-page":"1678","article-title":"Outcome of Henoch-Schoenlein purpura 8 years after the treatment with placebo or prednisone at disease onset [abstract no: PS2-FRI-493]","volume":"26","author":"Jauhola","year":"2011","journal-title":"Pediatric Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD005128.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00467-012-2106-z","article-title":"Outcome of Henoch-Schonlein purpura 8 years after treatment with a placebo or prednisone at disease onset","volume":"27","author":"Jauhola","year":"2012","journal-title":"Pediatric Nephrology"},{"issue":"11","key":"10.1002\/14651858.CD005128.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/adc.2009.182394","article-title":"Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children","volume":"95","author":"Jauhola","year":"2010","journal-title":"Archives of Disease in Childhood"},{"issue":"2","key":"10.1002\/14651858.CD005128.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jpeds.2006.03.024","article-title":"Early prednisone therapy in Henoch-Schonlein purpura: a randomized double-blind, placebo-controlled trial","volume":"149","author":"Ronkainen","year":"2006","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD005128.pub4-BIB0029|cit29","first-page":"421A","article-title":"Henoch-Schonlein purpura (HSP) nephritis: efficacy of cytoxan (C) & natural history. Report of the ISKDC [abstract]","volume":"49","author":"Tarshish","year":"2001","journal-title":"Pediatric Research"},{"issue":"1","key":"10.1002\/14651858.CD005128.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00467-003-1315-x","article-title":"Henoch-Schonlein purpura nephritis: course of disease and efficacy of cyclophosphamide","volume":"19","author":"Tarshish","year":"2004","journal-title":"Pediatric Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD005128.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3109\/0886022X.2015.1061668","article-title":"Heparin calcium treated Henoch-Schonlein purpura nephritis in children through inhibiting hyperfibrinolysis","volume":"37","author":"Tian","year":"2015","journal-title":"Renal Failure"},{"issue":"3","key":"10.1002\/14651858.CD005128.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/ped.12271","article-title":"Add-on therapy with montelukast in the treatment of Henoch-Schonlein purpura","volume":"56","author":"Wu","year":"2014","journal-title":"Pediatrics International"},{"issue":"3","key":"10.1002\/14651858.CD005128.pub4-BIB0033|cit33","first-page":"229","article-title":"Efficacy of fosinopril on proteinuria in children with Henoch-Schonlein purpura nephritis","volume":"11","author":"Xu","year":"2009","journal-title":"Zhongguo Dangdai Erke Zazhi"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0034|cit34","first-page":"C47","article-title":"Evaluation of the preventive role of dipyridamole and aspirin against renal complication in Schonlein-Henoch purpura [abstract]","volume":"1","author":"Yoshimoto","year":"1987","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0035|cit35","first-page":"C47","article-title":"Evaluation of the preventive role of dipyridamole and aspirin against renal complication in Schonlein-Henoch purpura [abstract]","volume":"1","author":"Yoshimoto","year":"1987","journal-title":"Pediatric Nephrology"},{"issue":"11","key":"10.1002\/14651858.CD005128.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/iju.14665","article-title":"Effect and safety evaluation of tacrolimus and tripterygium glycosides combined therapy in treatment of Henoch-Schonlein purpura nephritis","volume":"28","author":"Zhang","year":"2021","journal-title":"International Journal of Urology"},{"issue":"5","key":"10.1002\/14651858.CD005128.pub4-BIB0037|cit37","first-page":"283","article-title":"Effect of MORA bioresonance therapy in the treatment of Henoch-Schonlein purpura and influence on serum antioxidant enzymes","volume":"39","author":"Chen","year":"2010","journal-title":"Journal of Clinical Dermatology"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0038|cit38","unstructured":"Efficacy and side effects of different doses of Tripterygium Wilfordii granules combined with traditional Chinese medicine in the treatment of children with recurrent Henoch-Schonlein Purpura https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR2100050353"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0039|cit39","unstructured":"Effects of laminar flow bed on Henoch-Schonlein Purpura in children www.chictr.org.cn\/showproj.aspx?proj=20982"},{"issue":"1","key":"10.1002\/14651858.CD005128.pub4-BIB0040|cit40","first-page":"293","article-title":"Efficacy of Yupingfeng San for assisting in treatment of children with Henoch-Schonlein purpura and its effects on oxidative stress and the immune system","volume":"13","author":"Cui","year":"2020","journal-title":"International Journal of Clinical & Experimental Medicine"},{"issue":"5","key":"10.1002\/14651858.CD005128.pub4-BIB0041|cit41","first-page":"300","article-title":"Clinical trial of potenlin in allergic purpura of adults","volume":"24","author":"Ding","year":"1995","journal-title":"Journal of Clinical Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD005128.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0254-6272(14)60048-0","article-title":"Effects of Chinese herbs in children with Henoch-Schonlein purpura nephritis: a randomized controlled trial","volume":"34","author":"Ding","year":"2014","journal-title":"Journal of Traditional Chinese Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005128.pub4-BIB0043|cit43","first-page":"538","article-title":"Traditional Chinese medicine versus regular therapy in Henoch-Schonlein purpura nephritis in children: study protocol for a randomized controlled trial","volume":"20","author":"Ding","year":"2019","journal-title":"Trials [Electronic Resource]"},{"issue":"24","key":"10.1002\/14651858.CD005128.pub4-BIB0044|cit44","first-page":"7569","article-title":"Clinical study on different dosage of Tripterygium wilfordii Granules combined with Purpura No. I prescription in treating children with recurrent Henoch-Schonlein purpura","volume":"52","author":"Ding","year":"2021","journal-title":"Chinese Traditional & Herbal Drugs"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0045|cit45","unstructured":"Erdogan O Oner A Aydin A Isimer A Demircin G Bulbul M Lack of efficacy of vitamin e supplementation in decreasing the oxidative damage Henoch-Schonlein Purpura: a randomised controlled trial [abstract] Nephrology Dialysis Transplantation 1999 14 9 A46"},{"issue":"8","key":"10.1002\/14651858.CD005128.pub4-BIB0046|cit46","first-page":"797","article-title":"Clinical effect of alfacalcidol in children with Henoch-Schonlein purpura: a prospective randomized controlled trial","volume":"23","author":"Fu","year":"2021","journal-title":"Zhongguo Dangdai Erke Zazhi"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0047|cit47","doi-asserted-by":"crossref","unstructured":"Fukui H Kamitsuji H Nagao T Yamada K Akatsuka J Inagaki M Clinical evaluation of a pasteurized factor XIII concentrate administration in Henoch-Sch\u00f6nlein purpura. Japanese Pediatric Group Thrombosis Research 1989 56 6 667 75","DOI":"10.1016\/0049-3848(89)90284-3"},{"issue":"39","key":"10.1002\/14651858.CD005128.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"e12577","DOI":"10.1097\/MD.0000000000012577","article-title":"Effect of montmorillonite powder on intestinal mucosal barrier in children with abdominal Henoch-Schonlein Purpura: a randomized controlled study","volume":"97","author":"Gao","year":"2018","journal-title":"Medicine"},{"issue":"8","key":"10.1002\/14651858.CD005128.pub4-BIB0049|cit49","first-page":"C79","article-title":"Treatment of pediatric purpuric nephritis with Tripterygium wilfordii polyglucoside and radix salviac miltiorrhizae [abstract no: P85]","volume":"16","author":"Hui-Lan","year":"2001","journal-title":"Pediatric Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD005128.pub4-BIB0050|cit50","first-page":"C78","article-title":"Treatment of purpuric nephritis in children with Tripterygium wilfordii polyglucoside and Radix salviae miltiorrhizae [abstract no: P79]","volume":"16","author":"Hui-Lan","year":"2001","journal-title":"Pediatric Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD005128.pub4-BIB0051|cit51","first-page":"585","article-title":"Immune functional changes in patients of acute Henoch-Schonlein purpura and regulatory effect of integrated Traditional Chinese and Western medicine on it","volume":"21","author":"Jia","year":"2001","journal-title":"Zhongguo Zhongxiyi Jiehe Zazhi [Chinese Journal of Integrated Traditional & Western Medicine]"},{"issue":"4","key":"10.1002\/14651858.CD005128.pub4-BIB0052|cit52","first-page":"58","article-title":"Therapeutic effect of low-dose hepacarin in the childhood anaphylactoid purpura","volume":"9","author":"Jiang","year":"2003","journal-title":"Journal of Pediatric Pharmacy"},{"issue":"12","key":"10.1002\/14651858.CD005128.pub4-BIB0053|cit53","first-page":"905","article-title":"Effect of Danshao granule on serum superoxide dismutase activity and malonyldialdehyde content in children with Henoch-Schonlein purpura nephritis","volume":"23","author":"Jin","year":"2003","journal-title":"Zhongguo Zhongxiyi Jiehe Zazhi [Chinese Journal of Integrated Traditional & Western Medicine]"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0054|cit54","first-page":"7223613","article-title":"The efficacy of Tripterygium glycosides combined with LMWH in treatment of HSPN in children","author":"Jin","year":"2021","journal-title":"Evidence-based Complementary & Alternative Medicine: eCAM"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0055|cit55","unstructured":"Kim PK Jeong HJ Kim KS Lee JK Lee JS Choi IJ Rifampin therapy in Henoch-Schonlein Purpura nephritis accompanied by the nephrotic syndrome [abstract] 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK 1987 18"},{"issue":"1","key":"10.1002\/14651858.CD005128.pub4-BIB0056|cit56","first-page":"271","article-title":"Clinical application of compound Glycyrrhizin tablets in the treatment of patients with simplex Henoch-Schonlein Purpura and its effect on immune function","volume":"38","author":"Li","year":"2022","journal-title":"Pakistan Journal of Medical Sciences"},{"issue":"8","key":"10.1002\/14651858.CD005128.pub4-BIB0057|cit57","first-page":"701","article-title":"Clinical study on integrative Chinese and Western medicine in treating allergic purpura and preventing renal impairment","volume":"24","author":"Liu","year":"2004","journal-title":"Zhongguo Zhongxiyi Jiehe Zazhi [Chinese Journal of Integrated Traditional & Western Medicine]"},{"issue":"2","key":"10.1002\/14651858.CD005128.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11655-008-0132-2","article-title":"Clinical observation on the treatment of childhood refractory idiopathic thrombocytopenic purpura with Dihuang Zhixue capsule","volume":"14","author":"Liu","year":"2008","journal-title":"Chinese Journal of Integrative Medicine"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0059|cit59","unstructured":"Micheletti R Pagnoux C A randomized multicenter study for isolated skin vasculitis (ARAMIS) clinicaltrials.gov\/show\/NCT02939573"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0060|cit60","unstructured":"Sun L Huang W Clinical study on strategy for refractory Henoch-Sch\u00f6nlein Purpura clinicaltrials.gov\/show\/NCT03647852"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0061|cit61","unstructured":"Pillebout E Efficacy of colchicine to prevent skin relapses in adult's IgA vasculitis (COLCHIVAS) clinicaltrials.gov\/show\/NCT04008316"},{"issue":"1","key":"10.1002\/14651858.CD005128.pub4-BIB0062|cit62","first-page":"49","article-title":"Clinical effect and mechanism of total glucosides of paeony in the adjuvant therapy for children with Henoch-Schonlein purpura nephritis: a prospective randomized controlled study","volume":"23","author":"Shao","year":"2021","journal-title":"Zhongguo Dangdai Erke Zazhi [Chinese Journal of Contemporary Pediatrics]"},{"issue":"4","key":"10.1002\/14651858.CD005128.pub4-BIB0063|cit63","first-page":"504","article-title":"Effect of herbs in early intervention of children with Henoch-Schonlein purpura nephritis","volume":"31","author":"Wang","year":"2011","journal-title":"Zhongguo Zhongxiyi Jiehe Zazhi [Chinese Journal of Integrated Traditional & Western Medicine]"},{"issue":"8","key":"10.1002\/14651858.CD005128.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1136\/jim-2021-001984","article-title":"A randomized controlled trial on the effect of dietary guidance on the treatment of Henoch-Schonlein purpura in children","volume":"69","author":"Wang","year":"2021","journal-title":"Journal of Investigative Medicine"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"292865","DOI":"10.1155\/2013\/292865","article-title":"Efficacy of triptolide for children with moderately severe Henoch-Schonlein purpura nephritis presenting with nephrotic range proteinuria: a prospective and controlled study in China","volume":"2013","author":"Wu","year":"2013","journal-title":"BioMed Research International"},{"issue":"10","key":"10.1002\/14651858.CD005128.pub4-BIB0066|cit66","first-page":"988","article-title":"Clinical effect of gamma globulin pulse therapy for abdominal Henoch-Schonlein purpura in children","volume":"18","author":"Xia","year":"2016","journal-title":"Zhongguo Dangdai Erke Zazhi"},{"issue":"2","key":"10.1002\/14651858.CD005128.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11655-009-0149-1","article-title":"Effect of composite salvia injection on platelet parameters in children with anaphylactoid purpura","volume":"15","author":"Xie","year":"2009","journal-title":"Chinese Journal of Integrative Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005128.pub4-BIB0068|cit68","first-page":"168","article-title":"Clinical effect of alanyl-glutamine-enriched nutritional support in the treatment of children with abdominal Henoch-Schonlein purpura","volume":"21","author":"Xiong","year":"2019","journal-title":"Zhongguo Dangdai Erke Zazhi"},{"issue":"6","key":"10.1002\/14651858.CD005128.pub4-BIB0069|cit69","first-page":"449","article-title":"Controlled study on therapeutic effect of vessel pricking therapy and western medication for treatment of Henoch-Schonlein purpura nephritis","volume":"30","author":"Yang","year":"2010","journal-title":"Zhongguo Zhenjiu"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0070|cit70","unstructured":"Yi H Effect of Shenyankangfu tablet on urinary IL-6 and its therapeutic effect in children with Henoch-Schonlein purpura nephritis Zhongguo Dangdai Erke Zazhi 2007 9 2 153 4 17448314"},{"issue":"1","key":"10.1002\/14651858.CD005128.pub4-BIB0071|cit71","first-page":"26","article-title":"Clinical observation of anisodamine on treatment of anaphylactoid purpura by infused intravenously","volume":"4","author":"Zhang","year":"1984","journal-title":"Chinese Journal of Practical Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005128.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5428\/pcar20190309","article-title":"Therapeutic effect of Vitamin D on Henoch-Schonlein purpura in children and its influence on immune mechanism","volume":"19","author":"Zhang","year":"2019","journal-title":"Pharmaceutical Care & Research"},{"issue":"4","key":"10.1002\/14651858.CD005128.pub4-BIB0073|cit73","first-page":"351","article-title":"Preventive effect of integrative medical therapy on children Henoch-Schonleln purpura with renal impairment","volume":"29","author":"Zhao","year":"2009","journal-title":"Zhongguo Zhongxiyi Jiehe Zazhi [Chinese Journal of Integrated Traditional & Western Medicine]"},{"issue":"11","key":"10.1002\/14651858.CD005128.pub4-BIB0074|cit74","first-page":"2162","article-title":"Effect of tripterygium glycosides and Danshen injection on blood coagulation mechanism in children with allergic purpura nephritis","volume":"41","author":"Zhu","year":"2016","journal-title":"Zhongguo Zhongyao Zazhi [China Journal of Chinese Materia Medica]"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0075|cit75","unstructured":"Liu ZH Mycophenolate mofetil (MMF) versus intravenous CTX pulses in the treatment of adult severe HSPN www.clinicaltrials.gov\/ct2\/show\/NCT00301613"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0076|cit76","unstructured":"Zhang A The research of standard diagnosis and treatment for HSPN in children clinicalTrials.gov\/show\/NCT02532777"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0077|cit77","unstructured":"Zhang A The research of standard diagnosis and treatment for HSPN with mild proteinuria in children clinicalTrials.gov\/show\/NCT02532790"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0078|cit78","unstructured":"Zhang A The research of standard diagnosis and treatment for severe HSP in children ClinicalTrials.gov\/show\/NCT02540720"},{"issue":"1","key":"10.1002\/14651858.CD005128.pub4-BIB0079|cit79","first-page":"9","article-title":"Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy","volume":"49","author":"Bergstein","year":"1998","journal-title":"Clinical Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD005128.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2215\/CJN.06710810","article-title":"Henoch-Schonlein purpura nephritis: pathophysiology, treatment and future strategy","volume":"6","author":"Davin","year":"2011","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"5","key":"10.1002\/14651858.CD005128.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40272-021-00464-0","article-title":"Management of IgA vasculitis with nephritis","volume":"23","author":"Delbert","year":"2021","journal-title":"Pediatric Drugs"},{"issue":"5","key":"10.1002\/14651858.CD005128.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00467-011-2057-9","article-title":"Treatment of children with Henoch-Schonlein purpura nephritis with mycophenolate mofetil","volume":"27","author":"Du","year":"2012","journal-title":"Pediatric Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD005128.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000046235","article-title":"Treatment of Henoch-Schonlein Purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide","volume":"21","author":"Flynn","year":"2001","journal-title":"American Journal of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD005128.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1067\/mpd.2000.103448","article-title":"Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study","volume":"136","author":"Foster","year":"2000","journal-title":"Journal of Pediatrics"},{"issue":"8788","key":"10.1002\/14651858.CD005128.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0140-6736(92)91341-5","article-title":"Long-term follow-up of childhood Henoch Schonlein nephritis","volume":"339","author":"Goldstein","year":"1992","journal-title":"Lancet"},{"issue":"7650","key":"10.1002\/14651858.CD005128.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD005128.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7414","key":"10.1002\/14651858.CD005128.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0089|cit89","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD005128.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s004670050447","article-title":"Multiple combined therapy for severe Henoch Schonlein nephritis in children","volume":"12","author":"Iijima","year":"1998","journal-title":"Pediatric Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD005128.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis & Rheumatism"},{"issue":"4","key":"10.1002\/14651858.CD005128.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/ndt\/gfg617","article-title":"Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study","volume":"19","author":"Kawasaki","year":"2004","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4S","key":"10.1002\/14651858.CD005128.pub4-BIB0093|cit93","first-page":"S115","article-title":"KDIGO 2021 Clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","journal-title":"Kidney International"},{"issue":"9","key":"10.1002\/14651858.CD005128.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/adc.2005.074641","article-title":"Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review","volume":"90","author":"Narchi","year":"2005","journal-title":"Archives of Disease in Childhood"},{"issue":"3","key":"10.1002\/14651858.CD005128.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s004670050446","article-title":"Methylprednisolone pulse therapy in the treatment of severe forms of Schonlein-Henoch purpura nephritis","volume":"12","author":"Niaudet","year":"1998","journal-title":"Pediatric Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD005128.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/rheumatology\/kez041","article-title":"European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative","volume":"58","author":"Ozen","year":"2019","journal-title":"Rheumatology"},{"issue":"8","key":"10.1002\/14651858.CD005128.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/rheumatology\/kex158","article-title":"Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: a population-based study","volume":"56","author":"Piram","year":"2017","journal-title":"Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD005128.pub4-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5414\/CNP60080","article-title":"Outcome of Henoch-Schoenlein nephritis with nephrotic-range proteinuria","volume":"60","author":"Ronkainen","year":"2003","journal-title":"Clinical Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD005128.pub4-BIB0099|cit99","first-page":"790\u20137","article-title":"EULAR\/PRINTO\/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: overall methodology and clinical characterisation [Erratum in: Ann Rheum Dis. 2011 Feb;70(2):397 Note: Paut, Isabelle Kone [corrected to Kone-Paut, Isabella]]","volume":"69","author":"Ruperto","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"10.1002\/14651858.CD005128.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00005792-199911000-00005","article-title":"Henoch-Schonlein Purpura in children. Report of 100 patients and review of the literature","volume":"78","author":"Saulsbury","year":"1999","journal-title":"Medicine"},{"issue":"5","key":"10.1002\/14651858.CD005128.pub4-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0102|cit102","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0103|cit103","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"8","key":"10.1002\/14651858.CD005128.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00467-007-0498-y","article-title":"Treating severe Henoch-Schonlein and IgA nephritis with plasmapheresis alone","volume":"22","author":"Shenoy","year":"2007","journal-title":"Pediatric Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD005128.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/03009740510026841","article-title":"Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schonlein purpura","volume":"35","author":"Shin","year":"2006","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD005128.pub4-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1542\/peds.2007-0667","article-title":"Effects of corticosteroid on Henoch-Schonlein purpura: a systematic review","volume":"120","author":"Weiss","year":"2007","journal-title":"Pediatrics"},{"issue":"7644","key":"10.1002\/14651858.CD005128.pub4-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD005128.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s004670000517","article-title":"Evidence-based assessment of treatment options for children with IgA nephropathies","volume":"16","author":"Wyatt","year":"2001","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD005128.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1100\/tsw.2007.23","article-title":"Therapy for children with Henoch-Schonlein Purpura nephritis: a systematic review","volume":"7","author":"Zaffanello","year":"2007","journal-title":"Thescientificworldjournal"},{"issue":"1","key":"10.1002\/14651858.CD005128.pub4-BIB0110|cit110","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005128","article-title":"Interventions for preventing and treating renal disease in Henoch-Sch\u00f6nlein Purpura (HSP)","author":"Chartapisak","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005128.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/adc.2008.141820","article-title":"Prevention and treatment of renal disease in Henoch-Sch\u00f6nlein Purpura: a systematic review","volume":"94","author":"Chartapisak","year":"2008","journal-title":"Archives of Disease in Childhood"},{"issue":"3","key":"10.1002\/14651858.CD005128.pub4-BIB0112|cit112","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005128.pub2","article-title":"Interventions for preventing and treating kidney disease in Henoch-Sch\u00f6nlein Purpura (HSP)","author":"Chartapisak","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD005128.pub4-BIB0113|cit113","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005128.pub3","article-title":"Interventions for preventing and treatment of kidney disease in Henoch-Sch\u00f6nlein Purpura (HSP)","author":"Hahn","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T14:07:52Z","timestamp":1712153272000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005128.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":113,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005128.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]}}}